DatasetName,PRPF31_S(444) PRPF31_Y(435),PRPF31_S(307) PRPF31_S(404) PRPF31_S(432) PRPF31_S(433) PRPF31_S(439) PRPF31_S(445) PRPF31_S(450) PRPF31_S(451) PRPF31_T(434) PRPF31_T(440) PRPF31_T(449) PRPF31_T(455) PRPF31_T(499)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.5619269591080901
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5741252773258186
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,0.5607380286414803
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,0.563310765096811
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,0.5577863621295679
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.5661111232072011
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.3881753679033143,0.5614210002059601
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,0.6038430129179844
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.5569551142498314
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.5530321343193542
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5600001216951171
RB2022_8_RecoveryEndurance,,0.572111253712084
KBE2022_Log2_Ex_14_U,,0.5651879070445918
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.549186030655995
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,0.5560454484259565
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,0.5527224579675688
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5604907205456533
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.5663987707701966
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.3894815143982034,0.5610964994070011
KBE2022_Log2_Ex_34_U,,0.5624265024744564
WZ2023_Pu_005_10min,,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,
AH2018_SILAC_MR_2_X,,0.5561085058299141
HS2024_4_PD_T2,,0.5369006658935199
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,
FR2021_Norm.Intensity.B,,0.5598483817081469
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.5601761321126666
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5560820374189881
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5583532662930816
HS2024_7_PD_T2,,0.5584268336072211
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,0.5751871484105783
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.5584509452581126
HS2024_3_B_N1,,0.5716894956617211
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5507188361915513
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5929568580876912
FSO2013_Ratio H/L normalized Rep2,,0.5666703942317359
WZ2023_Pu_005_20min,,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.5680029652991017
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,0.5675959396410628
AH2018_LFQ_M_1_C,,0.5849096999558268
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.5760749124180168
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.5652355490234323
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,0.5460119482347691
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.5478836252505166
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.5810197050392129
PG2020_Intensity Mock_10h_D,,0.5442966293281514
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.5649890844675208
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,0.5642315245699416
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,0.5606169816037494
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,0.5609427307579099
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5603137977960032
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,0.558599278981909
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,0.5768286389118822
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.5591549024385876
HS2024_5_PD_T1,,0.5576695977169347
AH2018_LFQ_M_2_C,,0.5605340824544597
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.5635698039793074
YA2020_Reporter_intensity_Cancer_No.5,,0.5792881404100398
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5567592349269118
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.5631302618901854
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5647520366050708
YA2020_Reporter_intensity_Normal_No.1,,0.5807515290126241
HS2024_3_B_T1,,0.5622811016936738
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.5635301900792304
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5710629720225504
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,0.5629079116753584
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.5747509358290881
DL2023_12h-2,,0.5554832518953338
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,0.5639861773709509
WZ2023_Pu_010_20min,,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,0.5697010872478109
CK2022_8 16-1,,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,0.5710023567212343
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.577667319041737
FSO2013_Ratio H/M normalized Rep2,,0.5522726263715765
RAM2015_Log2 A,,
HS2024_8_PD_T1,,0.5536569303270747
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,0.590682170432687
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,0.5427773377287232
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.5476902004076833
AH2018_SILAC_M_3_X,,0.5519441994337185
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,0.5573418811746672
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.5731837331121836
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.5465610436136485
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.39272923928490766,0.5601566329870529
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,,0.5847520425466173
KBE2022_Log2_Ex_27_T,,0.5552333379831876
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5737941544544581
AH2018_SILAC_IT_3_X,,0.5546599952624258
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,0.5676861862378507
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.56417024203628
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5568708232830741
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.566127706289024
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.5759924040911328
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5741917826454445
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5567619983920015
CK2022_11 200-1,,0.5339147647055725
CK2022_12 200-1,,0.5286855467860182
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,
AH2018_TMTMS2_2_N,,0.5534963555448357
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5650693332719198
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,0.5697863191475849
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,,0.550861983691141
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5562671720421639
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5618881253969156
AST2020_anti-CD3+PDL2.2,0.3893522434976675,0.5610820078250894
PG2020_Intensity Mock_10h_A,0.40994091216098394,0.5478127603538249
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,0.566468833285078
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,
CF2017_EOC 1,,
CK2022_3 200-1,,0.5804665060740741
AH2018_LFQ_IT_3_C,,0.5573042736630833
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,0.5398931100617813
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.563581859274451
HS2024_5_B_T1,,0.5570435428299848
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.5582344411082146
RB2022_6_PreStrength,,0.5659634668182372
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5837543399151996
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.5573665030836186
HS2024_4_B_T1,,0.5491640184687708
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.5645443980514997
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.5504123105527392
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,
FS2019_db/db3,,0.5587204472912822
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5668340730295548
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5507627030448448
HS2024_5_PD_T3,,0.5546960997749599
AH2018_TMTMS3_3_X,,0.576468785885903
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.5628863366901329
AH2018_LFQ_M_1_N,,0.5387430655769064
KBE2022_Log2_Ex_27_U,,0.5535644981557769
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5783819339603842
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.5559716866910526
YA2020_Reporter_intensity_Normal_No.4,,0.5770532414823085
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5510012459986263
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.5612820646291573
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.5574201098856507
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.5626070688271676
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5487651260961969
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5519167925105621
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5495619550877974
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5597324496968236
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5652160182959858
KBE2022_Log2_Ex_19_U,,0.5607269023993275
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,0.568478076830017
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5317795817920516
AST2020_Control,0.3855964398910889,0.5626766906586917
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,0.5646793485404392
YA2020_Reporter_intensity_Normal_No.3,,0.5782025685637489
HS2024_8_B_T2,,0.5598243616638983
AH2018_LFQ_1_X,,0.5454055649196935
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,0.5479705525274609
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5792454651635041
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.57640349415226
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,0.5610110201358994
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.5623626966631273
CR2017_Ratio Replicate 2,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5592836600325846
AR2021_KD 72h,,0.5523508726191521
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.5631463326093935
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5699984288263255
KBE2022_Log2_Ex_9_U,,0.5567545254611008
AH2018_SILAC_M_3_N,,0.5651602091687409
KBE2022_Log2_Ex_13_T,,0.5634677521228627
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.3543369414110785,0.5519812329079095
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,0.5616722068737674
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5657314489642944
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,0.5441634890853414
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,0.5707435821907662
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,0.5543033180856851
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.5671758353899492
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5752561065005818
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.5639417723946873
CK2022_7 200-1,,0.5772994094032714
CK2022_5 200-1,,0.5748085731221296
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5619144029211666
AH2018_SILAC_MR_1_X,,0.5672314160254195
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,0.5581315278757545
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.5690431656069777
AH2018_SILAC_3_C,,0.5657547352893366
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,0.5540701577755164
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5515227439262986
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5629081883716671
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,0.5651617927402964
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.5815882469509388
KBE2022_Log2_Ex_9_T,,0.5626013872604397
AH2018_SILAC_IT_2_N,,0.5536190748937516
AH2018_SILAC_IT_1_X,,0.5549977245967394
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.5632135908513378
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5440681969927275
HS2024_4_I_N2,,0.5482283557437084
AH2018_TMTMS2_3_N,,0.5530590074331092
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.5501589170901269
WZ2023_Su_005_30min,,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,
WZ2023_Su_025_10min,,
AH2018_LFQ_IT_4_X,,0.5560509771468205
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.5580257839629806
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,0.5612645893517598
KS2014_Intensity,,0.580437260962724
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,0.5533293720423962
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.5630549371749114
RB2022_8_PostStrength,,0.5747068512371803
AH2018_SILAC_IT_2_X,,0.5492329664019129
HS2024_4_B_T3,,0.5596799727419322
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.5630951109631037
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.5773820229562032
KBE2022_Log2_Ex_6_U,,0.5653264902306124
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5514342339355014
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,,
CK2022_6 200-1,,0.5767039338472916
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5707927893937991
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,0.5708875697819196
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.5264530729567742
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,0.5594097059156009
HS2024_3_B_T3,,0.5693103520440391
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.5352166488941666
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5745207032770059
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,
RB2022_7_PostEndurance,,0.5433320886888435
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5573067638065994
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.5560732048590835
KBE2022_Log2_Ex_29_T,,0.5619934374672464
HS2024_7_I_T2,,0.563521365045546
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.5689379443272051
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,0.5479705525274609
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5668017559824012
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.3970405295966352,0.5458280861131558
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,0.5479016939196085
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.5724721513424835
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,
HS2024_8_PD_T2,,0.5512464680040241
FS2019_Ctr2,,0.5630944053159624
RB2022_6_PreEndurance,,0.5521772997777744
FR2021_Norm.Intensity.G,,0.5491884519868324
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.5666563320854447
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5667681345592569
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.5627151864512603
CR2017_Ratio Replicate 2.3,,0.5607078244180369
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,0.5828238150420361
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.5399355788053086
HS2024_3_PD_T3,,0.5546777565294957
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,0.5501975093864029
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5517197472994811
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.5626973765268082
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.5671654096445518
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.5534726955380388
PG2020_Intensity Mock_10h_B,,0.5359839184538714
WZ2023_Su_025_30min,,
AH2018_LFQ_4_N,,0.5639086845000902
CR2017_Ratio Replicate 1.2,,0.5559170180454542
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.5627364182266199
HS2024_8_I_N1,,0.5670143580317714
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.5666988784559888
RB2022_7_PreEndurance,,0.5651158172681761
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,0.5610306385835678
LY2019_P6+,,0.5560876476458702
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.55497804214598
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.5457710014171255
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5731475588939697
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.5620551414808233
KS2014_Intensity C5,,0.5864591210833675
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.5598576024696374
RNJ2017_Log2_ratio_Tstim:Trest_D2,,0.5647834733263486
GF2025_P9_Adh,,
RB2022_3_PostStrength,,0.5703382910334499
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.5585918173373208
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5432168284216482
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,0.534090127395512
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.5781853733965241
KS2014_Intensity E15_3,,0.5823557482493217
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5741382334429549
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5668305673275215
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.5611795859467367
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,
ZQ2022_N1,,
LY2019_P6-,,0.5536147321850737
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,0.5621624087736484
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.5537438958245331
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,0.5598383739792148
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.5449919327435647
WZ2023_Su_025_20min,,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,0.5602050192652585
LY2019_P8-,,0.5721753418818298
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5557332899444158
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,0.5511347449039016
HS2024_3_B_N2,,0.5556426154967533
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,0.5785953189975672
AH2018_SILAC_MR_3_C,,0.5596539339267842
AH2018_LFQ_M_4_C,,0.5576526472157829
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,0.5607120693951213
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.5541039771431522
LY2019_P3-,,0.5626540179240508
FR2021_Intensity.A,,0.543341203717082
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,
HS2024_8_PD_T3,,0.5608281238655474
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.3856427393220498,0.5612318918917614
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,0.5592135697012967
WZ2023_Pu_025_20min,,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,0.5450452185151866
HS2024_5_B_N1,,0.5591034378792106
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.5564650890236822
RB2022_4_PreSprint,,0.5630574634943101
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5726133518235702
HS2024_8_I_N2,,0.5623496756945321
RB2022_3_RecoveryStrength,,0.580859862048452
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5772621247048134
LY2019_P8+,,0.5713980587706761
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5444524535511343
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5647890717750802
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.5589095620962181
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,0.5775059493367121
AH2018_LFQ_IT_1_X,,0.56583500144945
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,,
AST2020_Control.2,0.38708695755805067,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.5655502225050129
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,0.5600076741288914
HS2024_6_I_T1,,0.5599437586093999
HS2024_5_B_T3,,0.5584679520692194
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.5571997077308586
AH2018_TMTMS3_3_N,,0.5624690012041863
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,0.5450479801115848
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5664733303805259
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,,0.5551866600300384
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,
KS2014_Intensity C2,,0.590550834264012
FSO2013_Ratio H/L normalized Rep1___2,,0.5576233966202803
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.5672684894925701
CK2022_9 200-1,,0.5381978807545098
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5381382083641243
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.5634539565145406
RBK2021_1332T Late,,
LY2019_P1-,,0.5561743776817133
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,
HS2024_3_I_T3,,0.5626192761057502
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5907275269710789
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.5707026626942627
FSO2013_Ratio H/M normalized Rep3___2,,0.5563627330360726
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,0.5699024101153378
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5550214885099238
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5654075463856564
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,0.5702734628226837
HS2024_5_I_N1,,0.5564552459131953
HS2024_6_I_N1,,0.5649180009515887
AR2021_KD 48h,,0.5509593566631298
FR2021_Intensity.B,,0.5598374366383029
RB2022_3_PreEndurance,,0.5517638264690894
HS2024_5_I_T1,,0.5634985307959167
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.3810902164332246,0.5623908009271951
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,
KBE2022_Log2_Ex_29_U,,0.5562098471509663
HS2024_7_B_T1,,0.5596847464096829
AH2018_LFQ_M_2_X,,0.5354946395171538
AH2018_LFQ_IT_4_N,,0.5647216200842878
CK2022_15 200-1,,0.5497414173444102
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.5643441958343031
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5696816404834943
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.5785436675821347
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,,0.5594618683567071
YA2020_Reporter_intensity_Cancer_No.3,,0.5862555063421757
KBE2022_Log2_Ex_44_U,,0.5620526093196656
WZ2023_Pe_010_20min,,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,0.5661989180968169
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.583642227144461
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,0.5671849914140797
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5601147058672252
AH2018_SILAC_M_2_X,,0.5486274839656721
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.5580032697260294
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5689427265910976
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.5562848519622591
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,0.5412457365991165
FSO2013_Ratio H/L normalized Rep3___2,,0.5671667278010144
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,0.5662447025502025
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,0.5604068352850623
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,0.5651640313726388
CF2017_EOC 2,,
RB2022_6_PostEndurance,,0.5506822560770378
AH2018_SILAC_1_N,,0.5776586603929031
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.568060488701725
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.5588400196253848
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,0.5697192947032412
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5424708429661259
AR2021_L41 1 μM,,0.5619862378723565
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.55826008692704
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,0.5929633317633405
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.5613381863158311
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,0.5732384598244725
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,0.5651503968946741
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5700003620451315
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5663556065745515
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.5529352488181856
AH2018_SILAC_IT_3_C,,0.575304591867006
WZ2023_Pu_025_10min,,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5567368272745251
KS2014_Intensity C6,,0.5782865198129498
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,0.5594333976696689
CK2022_5 40-1,,
AH2018_LFQ_3_X,,0.5565598691708019
UK2020_UA_3,,
LY2019_P7-,,0.5466216876889933
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.5669982139497081
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,0.5667219535928025
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.5663384445911691
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,0.5572315107171351
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5610360235156648
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5599410515821984
YA2020_Reporter_intensity_Cancer_No.4,,0.5782938699013245
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.5660160480871095
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,0.5460119482347691
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,0.38480043121758584,0.56148765526174
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.5501600705672921
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5530075649052126
HS2024_8_I_T1,,0.565942063007763
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,,0.5455888713485286
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,0.572198110034648
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,0.5627509780963895
AH2018_SILAC_1_X,,0.5657742957417818
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.5715419179774044
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.5592194263754428
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5605613568870772
HS2024_5_I_N2,,0.5405796350976346
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
